Latest news with #Sutter
Yahoo
24-07-2025
- Business
- Yahoo
Sutter Health names new chief operating officer
This story was originally published on Healthcare Dive. To receive daily news and insights, subscribe to our free daily Healthcare Dive newsletter. Name: Kevin Manemann Previous title: Executive vice president and chief integration officer, City of Hope New title: Chief operating officer, Sutter Health Manemann, an executive with more than two decades of leadership experience in large health systems, will be Sutter Health's next chief operating officer, the Sacramento, California-based system announced Tuesday. He'll be filling a role that's sat vacant since March, when previous COO Mark Sevco left Sutter to become the CEO of Pittsburgh-based Alleghany Health Network. Manemann, who assumes his new role on Sept. 15, was formerly an executive at Southern California-based City of Hope, a $6 billion cancer care system. Prior to that, Manemann held several leadership roles at Providence St. Joseph Health, the third-largest nonprofit health system in the U.S. — including leading a $10 billion division overseeing Northern and Southern California. Manemann was at Providence for more than 16 years, according to his LinkedIn. Manemann's selection as COO is the latest in a string of executive appointments for Sutter. The system named a new chief financial officer in May, a new chief scientific officer and chief nurse officer in January, and a new senior vice president of population health in December. At Sutter, Manemann will work closely with the system's chief physician executive to co-lead clinical and nonclinical operations, according to the release. Manemann's specific purview includes Sutter's operating structure, service lines, ambulatory surgery centers, nursing and home care. One of his priorities will be to support Sutter's ambulatory growth plans, the release said. The system, already a powerhouse in Northern California with more than two dozen hospitals, has been steadily snapping up more of the region's care delivery market, adding roughly 1,000 doctors and advanced practice clinicians in 2024. Sutter also opened or expanded a number of care centers last year, while announcing other capital projects, including an advanced neurological and neurosurgical care complex and a comprehensive cancer center. The system is also pursuing growth through a joint venture with SCAN Health Plan to offer new Medicare Advantage products next year, and a deal with GE Healthcare to integrate artificial intelligence into its operations. Amid these initiatives, Sutter's finances have remained relatively stable compared to some of its nonprofit peers, according to ratings agencies. Still, the system hasn't been immune to pressures hitting hospitals, including rising costs of labor and medical supplies. Sutter reported $142 million in operating income in 2024, down from $320 million the year prior. Though, hefty investment income in both years hiked Sutter's profits to $1 billion and $1.2 billion in 2024 and 2023, respectively. Sutter is also dealing with other operational challenges facing providers, including contract spats with major insurers. Sutter also been hit with multimillion-dollar settlements this year to settle legal actions over alleged anticompetitive behavior, retirement plan mismanagement and fraudulent billing for anesthesia services. Recommended Reading Sutter Health taps new CFO
Business Wire
22-07-2025
- Health
- Business Wire
Sutter Health Hospitals Deploy Wearable Ultrasound Tech to Personalize Fluid Management for Sepsis
SACRAMENTO, Calif. & LOS ANGELES--(BUSINESS WIRE)--Sutter Health, an integrated not-for-profit healthcare system based in Northern California, and Flosonics Medical today announced an expansion of the deployment of FloPatch, the first wireless wearable Doppler ultrasound device, across multiple hospital sites to support more precise and timely intravenous (IV) fluid management. This multisite deployment includes Sutter's Alta Bates Summit Medical Center, Summit Campus in Oakland and Sutter Santa Rosa Regional Hospital in Sonoma County. Implementations span the Emergency Department, Intensive Care Unit, Medical-Surgical Unit and Telemetry Unit. With these additions, six Sutter hospital campuses have now deployed FloPatch over the past year and include Sutter's Eden Medical Center in Castro Valley, Sutter's CPMC in San Francisco at CPMC Van Ness, Davies and Mission Bernal Campuses. IV fluid overload is a common complication in emergency and intensive care settings, in part because predicting a patient's response to fluids is complex. Individual needs can vary widely and shift quickly during critical illness. In studies of patients with sepsis and septic shock – a life-threatening condition caused by the body's overwhelming response to infection – nearly one-third were found to be fluid unresponsive¹. Without early identification of fluid unresponsiveness, patients may receive excessive fluids, increasing their risk of serious complications such as pulmonary edema, where fluid accumulates in the lungs. By some estimates, fluid overload can extend the average hospital stay by three days and increase healthcare costs by more than $15,000 per patient². FloPatch is an FDA-cleared, wearable device that provides clinicians with a fast and non-invasive way to perform hemodynamic assessments, measuring a patient's heart and blood flow response to IV fluids to help guide personalized fluid therapy. Clinical studies have shown that dynamic fluid assessments can reduce the need for mechanical ventilation and renal replacement therapy³,⁴, decrease ICU length of stay⁴, and are associated with lower mortality⁵. 'Our previous method of assessing fluid responsiveness was cumbersome and time-consuming. We often had to pull ICU nurses to perform evaluations in other units, which was disruptive and inefficient,' said Dr. Nader Emami, ICU medical director at Sutter Santa Rosa Regional Hospital. 'FloPatch streamlines the process with a simple, wearable device that empowers any member of the care team to perform this essential assessment faster and easier.' 'In emergency care, we often treat patients with complex needs, including people with sepsis,' said Dr. John Skovran, Emergency Department medical director at Sutter's Alta Bates Summit Medical Center, Summit Campus. 'We need a fast, reliable way to determine whether they'll benefit from fluids or be harmed by them. FloPatch gives us that clarity at the bedside in minutes, helping us make confident, timely decisions.' Joe Eibl, chief executive officer and co-founder of Flosonics Medical, noted: 'Sutter Health's multisite adoption of FloPatch reflects a growing recognition that wearable, real-time technologies play a transformative role in patient care. It's a great example of how forward-thinking health systems are meeting critical challenges with innovation.' Sutter Health prioritized staff training and thoughtfully integrated FloPatch into clinical workflows to make it a seamless part of care in intensive care and emergency medicine departments. About Sutter Health: Sutter Health is a not-for-profit healthcare system dedicated to providing comprehensive care throughout California. Committed to health equity, community partnerships, and innovative, high-quality patient care, Sutter Health is pursuing a bold new plan to reach more people and make excellent healthcare more connected and accessible. Currently serving more than 3.5 million patients, thanks to our dedicated team of more than 60,500 employees and clinicians, and 14,000+ physicians and advanced practice clinicians, with a unified focus on expanding care to serve more patients. Sutter delivers exceptional and affordable care through its hospitals, medical groups, ambulatory surgery centers, urgent care clinics, telehealth, home health, and hospice services. Dedicated to transforming healthcare, at Sutter Health, getting better never stops. Learn more about how Sutter Health is transforming healthcare at and About Flosonics Medical: Flosonics Medical is a medical device company engaged in the research and development of innovative ultrasound technology. Founded in 2015, the company's mission is to improve patient care and the practice of medicine through technology-enabled solutions and groundbreaking clinical research. For more information, please visit References: ¹ Hernández G, Ospina‑Tascón GA, Damiani LP, et al; ANDROMEDA‑SHOCK Investigators. Effect of a resuscitation strategy targeting peripheral perfusion status vs serum lactate levels on 28‑day mortality among patients with septic shock: the ANDROMEDA‑SHOCK randomized clinical trial. JAMA. 2019 Feb 19;321(7):654–664. doi:10.1001/jama.2019.0071 ² American Hospital Directory analysis of FFY2022 Medicare IPPS (MedPAR) claims data ³ Douglas IS, Alapat PM, Corl KA, Exline MC, Forni LG, Holder AL, et al. Fluid Response Evaluation in Sepsis Hypotension and Shock: A Randomized Clinical Trial. Chest. 2020 Oct;158(4):1431–1445. doi:10.1016/ ⁴ Latham HE, Bengtson CD, Satterwhite L, et al. Stroke volume–guided resuscitation in severe sepsis and septic shock improves outcomes. J Crit Care. 2017 Dec;42:42–46. doi:10.1016/ ⁵ Dubin A, Loudet C, Kanoore Edul VS, et al. Characteristics of resuscitation, and association between use of dynamic tests of fluid responsiveness and outcomes in septic patients: results of a multicenter prospective cohort study in Argentina. Ann Intensive Care. 2020 Apr 15;10(1):40. doi:10.1186/s13613-020-00659-7
Yahoo
10-07-2025
- Health
- Yahoo
Sutter's CPMC Debuts Sound Wave Therapy to Fight Hard-to-Treat Liver Tumors
With Histotripsy, Sutter Enhances Its Advanced Organ Therapies Program And Sets A New Standard For Delivering Personalized Liver Care San Francisco, July 10, 2025 (GLOBE NEWSWIRE) -- Physicians at Sutter's CPMC in San Francisco are using a leading-edge medical technology to care for people with liver tumors. FDA-approved histotripsy uses quick, highly focused sound waves to break apart unwanted tissue, such as tumors, without any incisions. These tiny, precise 'pulses' of energy, generated by a specialized machine, gently break down or 'dissolve' tumors inside the liver, which can be harder to treat give their location next to important blood vessels. This treatment can be a safer, less invasive option for some people for whom traditional surgical methods, chemotherapy or radiation have posed increased risks or have been ineffective. 'This really feels like the dawn of a new era,' said Dr. Casey Ward, transplant surgeon and CPMC's surgical director of Living Donor Liver Transplant and Transplant Oncology. 'Sutter's CPMC has always been a destination for exceptional care, offering game-changing treatments. Being one of the first in California to offer this new technology means we're pushing the boundaries of what's possible in organ therapies – and giving patients more options, and more hope, than ever before.' How it Works A highly skilled, multidisciplinary team at Sutter's CPMC uses Edison® System histotripsy, which features an ultrasound machine connected to a mobile robotic arm. The arm is positioned above the patient's abdomen to more precisely and safely target the liver tumor or tumors. After the procedure the patient will typically spend a night in the hospital before being discharged home. Dr. Ward, along with Dr. Olufoladare Olorunsola and Dr. Brian Bronzo, board-certified interventional radiologists at CPMC, are amongst the first physicians in Northern California trained to skillfully perform the procedure and deliver follow-up care so each patient heals and recovers. Training is currently underway with other CPMC physicians as well. Advantages of Histotripsy Histotripsy can support an easier recovery compared with traditional approaches like radiation, which uses targeted X-rays or energy to kill cancer cells, or ablation, which uses heat or cold to destroy tumors. The procedure can also serve as a 'bridge to transplant' for some patients, shrinking their tumor so it can be surgically removed before a new organ is required. Research shows that histotripsy may also stimulate the body's immune system to attack and kill tumor cells, known as the abscopal effect. This effect has been seen in patients following both radiation therapy and ablation, and can produce a similar effect with certain patients who have undergone histotripsy. Leading Advanced Organ Therapies and Cancer Care into the Future Histotripsy at Sutter's CPMC is part of its growing Advanced Organ Therapies program, which provides integrated, minimally invasive and multidisciplinary care to patients who have liver, kidney and pancreas diseases – as well as metabolic disorders that increase risk of cardiovascular disease, Type 2 diabetes and stroke. The program supports patients at every stage of their care, offering proactive management before and after surgery, with a focus on preventing or delaying the need for transplants whenever possible. In addition to advanced surgical and interventional therapies like histotripsy, the program also includes specialized weight management services, an enhanced support clinic for patients with complex needs, dedicated transplant coordination, and substance use disorder programs, helping patients receive personalized, whole-person care. Additionally, histotripsy, as one of Sutter's newest treatments, is now a key part of transplant oncology services within the Sutter system, supporting patients whose aggressive cancers have spread to their liver. 'Whether it is through leading breakthrough research, harnessing the power of the latest technology or embracing the use of creative and complementary therapies, our team's singular focus is putting patients first,' said Dr. Amanda Wheeler, Sutter Health's Cancer Service Line chair. 'With Sutter's integrated system as the engine, we are driving toward higher-quality outcomes and better patient experiences.' Currently, histotripsy is only U.S. FDA-approved for tumors in the liver. For more information about histotripsy at Sutter's CPMC, call 415-600-1010 or visit: # # # CONTACT: Liz Madison Sutter Health 916-396-5156 in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
02-07-2025
- Sport
- Yahoo
Alabama lands commitment from 2026 4-star tight end prospect
In what was only hours after the program secured a commitment from top 2026 running back Ezavier Crowell, the Alabama Crimson Tide also landed a tight end late Thursday night in Mark Sutter. Sutter's commitment to the Crimson Tide was announced via a post on social media. Advertisement At the moment, Sutter currently ranks as the nation's No. 80 overall prospect in the 2026 recruiting class, according to the 247Sports Composite rankings, as well as the No. 6 tight end this cycle. A four-star prospect, Sutter is also considered as the No. 1 overall prospect in the state of Illinois where he attends Dunlap High School. Following the commitment of Sutter to Alabama, the Crimson Tide's 2026 class is currently up to No. 11 nationally, according to the 247Sports Team Rankings with a total of 12 commitments. Contact/Follow us @RollTideWire on X (formerly Twitter) and like our page on Facebook to follow ongoing coverage of Alabama news, notes and opinion. This article originally appeared on Roll Tide Wire: 2026 tight end Mack Sutter commits to Alabama football
USA Today
27-06-2025
- Sport
- USA Today
Alabama lands commitment from 2026 4-star tight end prospect
BREAKING: Four-Star TE Mack Sutter has Committed to Alabama, he tells me for @on3recruitsThe 6'6 225 TE from Dunlap, IL chose the Crimson Tide over Ohio State, Illinois, & Ole Miss'T-town let's do ittt. ROLL TIDE!' In what was only hours after the program secured a commitment from top 2026 running back Ezavier Crowell, the Alabama Crimson Tide also landed a tight end late Thursday night in Mark Sutter. Sutter's commitment to the Crimson Tide was announced via a post on social media. At the moment, Sutter currently ranks as the nation's No. 80 overall prospect in the 2026 recruiting class, according to the 247Sports Composite rankings, as well as the No. 6 tight end this cycle. A four-star prospect, Sutter is also considered as the No. 1 overall prospect in the state of Illinois where he attends Dunlap High School. Following the commitment of Sutter to Alabama, the Crimson Tide's 2026 class is currently up to No. 11 nationally, according to the 247Sports Team Rankings with a total of 12 commitments. Contact/Follow us @RollTideWire on X (formerly Twitter) and like our page on Facebook to follow ongoing coverage of Alabama news, notes and opinion.
